Human papillomavirus vaccination for adult women
- PMID: 35820426
- PMCID: PMC9948262
- DOI: 10.1055/s-0042-1751331
Human papillomavirus vaccination for adult women
Conflict of interest statement
None to declare.
References
-
- Drolet M, Bénard E, Pérez N, Brisson M.HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis Lancet 2019394(10197):497–509.10.1016/S0140-6736(19)30298-3 - DOI - PMC - PubMed
-
- American Cancer Society Guideline Development Group . Saslow D, Andrews K S, Manassaram-Baptiste D, Smith R A, Fontham E TH. Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. CA Cancer J Clin. 2020;70(04):274–80. doi: 10.3322/caac.21616. - DOI - PubMed
-
- Ministério da Saúde. Secretaria de Vigilância em Saúde Departamento de Imunização e Doenças TransmissíveisCoordenação Geral do Programa Nacional de Imunizações. [Official Letter No 203/2021/CGPNI/DEIDT/SVS/MS. Expansion of the age range of the HPV vaccine for women with immunosuppression up to 45 years] [Internet]. 2021 [cited 2022 Jan 10]. Available from: https://sbim.org.br/images/files/notas-tecnicas/vacina-hpv-crie-45-anos.pdf. Portuguese.
-
- ICO/IARC Information Centre on HPV and Cervical Cancer (HPV Information Centre)Human papillomavirus and related diseases in the world. Summary Report 2019 [Internet]. 2019 [cited 2019 Jul 3]. Available from:https://www.hpvcentre.net/statistics/reports/XWX.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources